SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug firsekibart tested for rare Skin-Hardening disease
Disease control Not yet recruitingThis study tests a new drug called firsekibart in 30 people with a type of systemic sclerosis (scleroderma) that affects the skin. The goal is to see if the drug can improve skin thickness and other symptoms. Participants will receive the drug and be compared to similar patients …
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Fat stem cells may unlock tight mouths in scleroderma patients
Symptom relief Not yet recruitingThis study tests whether injections of donated fat-derived stem cells around the mouth can reduce fibrosis (scar-like tightness) and improve daily function in 50 adults with systemic scleroderma. Participants receive either the cell injections or a placebo, and changes in mouth h…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
Scientists investigate faulty immune cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to understand why certain immune cells (B cells) attack the body in autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults to identify and measure these harmful cells. The goal is to improve future treatments by targ…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC